Biscayne NeuroTherapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 27, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $3,000,000
Company Info
- Founders
- Stephen Collins
- Company Description
- Biscayne Neurotherapeutics is a clinical-stage biotechnology company which develops novel drugs for central nervous system disorders.
- Market
- Central Nervous System Disorders
- Location
- Miami, FL, USA
- Coinvestors
- GF Securities, Mesa Verde Venture Partners, Quark Venture